| 4CMH: reference: SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent anti-tumor activity in models of multiple myeloma and other CD38+ hematologic malignancies., Deckert J, Wetzel MC, Bartle LM, Skaletskaya A, Goldmacher V, Vallee F, Zhou-Liu Q, Ferrari P, Pouzieux S, Lahoute C, Dumontet C, Plesa A, Chiron M, Lejeune P, Chittenden T, Park PU, Blanc V, Clin Cancer Res. 2014 Jul 1. pii: clincanres.0695.2014. PMID: 24987056 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).